UPDATE : Monday, February 17, 2020
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits?
MSD is expected to announce the results of a study, whether Steglatro (ingr...
by Kim Yun-mi  |  2020-01-14 15:28
Genexine becomes largest shareholder of GenNBio
GenNBio said that Genexine has become its largest shareholder. The announce...
by Lee Han-soo  |  2020-01-14 11:11
Daewoong, A2A to develop AI-based anticancer treatment
Daewoong Pharmaceutical said that it would develop an anticancer treatment ...
by Lee Han-soo  |  2020-01-14 10:35
GSK shows meaningful response rate for treatment of multiple myeloma
GSK Korea said that treatment with the investigational single-agent belanta...
by Lee Han-soo  |  2020-01-13 17:48
Zejula widens indication as monotherapy for ovarian cancer
Takeda’s PARP (poly ADP-ribose polymerase) inhibitor Zejula (ingredient: ni...
by Kim Yun-mi  |  2020-01-13 16:25
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint
Vivozon said that it has started on a design change for its phase 3b clinic...
by Lee Han-soo  |  2020-01-13 16:22
Lilly secures atopic dermatitis drug through Dermira acquisition
Lilly has enhanced its immune disease pipelines by obtaining the rights to ...
by Kim Yun-mi  |  2020-01-13 14:05
Latecomer Bavencio improves overall survival in bladder cancer trial
Bavencio (ingredient: avelumab), a latecomer in the Tecentriq-led immune ch...
by Kim Yun-mi  |  2020-01-10 14:23
HLB gets UAE’s nod for joint company with local partner
Elevar therapeutics, a U.S. subsidiary of HLB, said that the United Arab Em...
by Lee Han-soo  |  2020-01-08 16:31
Daewoong, Avacta to establish joint venture
Daewoong Pharmaceutical said that it plans to set up a joint venture (JV) w...
by Lee Han-soo  |  2020-01-08 12:25
Genexine licenses out immunosuppressant candidate to GenNBio
Genexine said that it has licensed out BSF-110, a dual-fusion immunosuppres...
by Lee Han-soo  |  2020-01-07 17:35
Mundipharma to market Biosolution's knee cartilage defect treatment
Biosolution said that it has signed an exclusive sales agreement with Mundi...
by Lee Han-soo  |  2020-01-07 16:11
Fenbendazole craze expands to human parasiticide
Following the craze over fenbendazole, a dog deworming drug, in treating ca...
by Lee Han-soo  |  2020-01-07 12:33
Eliquis price cut delayed amid prolonged administrative suit
The Ministry of Health and Welfare’s order in June to cut the price of BMS ...
by Kim Yun-mi  |  2020-01-07 11:32
Chinese drugmaker Mebo establishes branch in Korea
Mebo Group, a Chinese firm specializing in regenerative medicine, has estab...
by Lee Han-soo  |  2020-01-06 14:40
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
After the regulator kicked ranitidine and nizatidine out of the market due ...
by Jeong Sae-im  |  2020-01-03 17:56
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
Bukwang Pharmaceutical said that it would promote and market Aprovel and Co...
by Lee Han-soo  |  2020-01-03 17:55
Daewoong launches oral typhoid fever vaccine
Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid ...
by Lee Han-soo  |  2020-01-03 17:55
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
If a person gets sick, he or she visits a doctor, gets a prescription, take...
by Lee Han-soo  |  2020-01-03 14:57
SK Bioscience’s influenza vaccine nabs WHO certification
SK Bioscience said that the World Health Organization (WHO) has granted pre...
by Lee Han-soo  |  2020-01-03 14:14
Back to Top